Raymond James Upgrades Oak Street Health to Outperform, Announces $35 Price Target
Raymond James analyst John Ransom upgrades Oak Street Health (NYSE:OSH) from Market Perform to Outperform and announces $35 price target.
Crude Oil Rises Over 1%; Oak Street Health Shares Spike Higher
U.S. stocks traded slightly higher midway through trading, with the Dow Jones around than 30 points on Tuesday.
Coinbase Discloses Restructuring Plan Amid Macro Headwinds, Pfizer Rebuts Generic Version Of COVID-19 Oral Treatment In China, Microsoft Mulls $10B Investment In ChatGPT Owner: Today’s Top Stories
Benzinga
Coinbase Bows Down To Macro Headwinds, To Let Go Of 950 Employees
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Prenetics Global (NASDAQ:PRE) stock rose 74.7% to $3.25 during Tuesday’s pre-market session. The market value of their…
Why VYNE Therapeutics Shares Are Trading Higher By 82%; Here Are 20 Stocks Moving Premarket
Gainers
VYNE Therapeutics Inc. (NASDAQ: VYNE) rose 82.2% to $0.35 in pre-market trading after the company said first vitiligo patient was dosed in Phase 1a/b clinical trial of novel BET inhibitor VYN201.
UBS Maintains Neutral on Oak Street Health, Lowers Price Target to $21
UBS analyst Andrew Mok maintains Oak Street Health (NYSE:OSH) with a Neutral and lowers the price target from $28 to $21.
Raymond James Downgrades Oak Street Health to Market Perform
Raymond James analyst John Ransom downgrades Oak Street Health (NYSE:OSH) from Outperform to Market Perform.
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Gainers
Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
Gainers
Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.